Sally is a Trainee Attorney within the Biotechnology group where she is involved in patent drafting, filing and prosecution.
Sally completed her PhD at the Peter MacCallum Cancer Centre under the guidance of Professor Ian Campbell. Her studies spanned a number of key disciplines including cancer genetics and genomics, high-throughput screening, RNA interference and targeted therapeutic development. During the course of her studies, she identified a number of genes that may be targeted for the treatment of advanced ovarian cancer. She also established an international collaboration with research groups in the United States and Canada to analyse gene expression in a large cohort of ovarian cancer patients. Results from her research have been published in peer-reviewed scientific journals and presented at domestic and international conferences.